Captrust Financial Advisors Frequency Therapeutics, Inc. Transaction History

Captrust Financial Advisors

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$4.95 - $7.11 $128 - $184	-26 Reduced 0.27%	9,488 $49,000
Q3 2021 Nov 16, 2021	BUY	$6.96 - $9.25 $180 - $240	26 Added 0.27%	9,514 $67,000
Q2 2021 Aug 16, 2021	SELL	$8.05 - $11.61 $392,840 - $566,568	-48,800 Reduced 83.72%	9,488 $95,000
Q1 2021 May 17, 2021	SELL	$7.99 - $55.01 $200,053 - $1.38 Million	-25,038 Reduced 30.05%	58,288 $554,000
Q4 2020 Feb 16, 2021	BUY	$18.65 - $40.0 $1.55 Million - $3.33 Million	83,326 New	83,326 $2.94 Million

Ticker FREQ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,262,000
Description
Frequency Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing therapeutics to activate a person's innate regenerative potential to restore function. Its Progenitor Cell Activation approach uses small molecules and activate progenitor cells within the body to create functional tissue. The company's lead product candi...

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

Stay updated on Captrust Financial Advisors with notifications on news.